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The effects of a probiotic formulation (Lactobacillus rhamnosus
and L. helveticus) on developmental trajectories of emotional
learning in stressed infant rats
CSM Cowan1, BL Callaghan1,2,3 and R Richardson1
Recently, scientific interest in the brain–gut axis has grown dramatically, particularly with respect to the link between
gastrointestinal and psychiatric dysfunction. However, the role of gut function in early emotional dysregulation is yet to be
examined, despite the prevalence and treatment resistance of early-onset psychiatric disorders. The present studies utilized a
developmental rodent model of early-life stress (ELS) to explore this gap. Rats were exposed to maternal separation (MS) on
postnatal days 2–14. Throughout MS, dams received either vehicle or a probiotic formulation (previously shown to reduce
gastrointestinal dysfunction) in their drinking water. Replicating past research, untreated MS infants exhibited an adult-like profile
of long-lasting fear memories and fear relapse following extinction. In contrast, probiotic-exposed MS infants exhibited age-
appropriate infantile amnesia and resistance to relapse. These effects were not mediated by changes in pups’ or dams’ anxiety at
the time of training, nor by maternal responsiveness. Overall, probiotics acted as an effective and non-invasive treatment to restore
normal developmental trajectories of emotion-related behaviors in infant rats exposed to ELS. These results provide promising
initial evidence for this novel approach to reduce the risk of mental health problems in vulnerable individuals. Future studies are
needed to test this treatment in humans exposed to ELS and to elucidate mechanisms for the observed behavioral changes.
Translational Psychiatry (2016) 6, e823; doi:10.1038/tp.2016.94; published online 31 May 2016
INTRODUCTION
The experience of early-life stress (ELS) is known to increase
vulnerability to a range of psychopathologies, including anxiety.1–3
This is particularly concerning given that anxiety disorders
emerging during childhood or adolescence tend to be symptoma-
tically more severe and more resistant to treatment compared with
adult-onset disorders.4,5 Treatments that target at-risk children, such
as those exposed to ELS, could be particularly effective in reducing
the prevalence and severity of early-onset disorders. However, the
use of traditional psychotropic medications during development is
controversial, in part because of a lack of information about long-
term effects for the developing central and peripheral nervous
systems.6 Thus, it is important to identify alternative methods of
reducing the risk of psychopathology using treatments that may
affect the central nervous system indirectly.
One potential target here is the brain–gut–microbiota axis. This
complex network comprises the brain, the gastrointestinal system,
and its resident bacteria (the microbiota, consisting of a
staggering 1013–1014 microorganisms).7 Accumulating evidence
points to a strong bidirectional communication between these
structures that is amplified in conditions of stress.7,8 Epidemiolo-
gical research and animal studies of the maternal separation (MS)
model show that ELS causes dysregulation throughout the brain–
gut–microbiota axis, rendering exposed individuals susceptible to
both gastrointestinal and mental health problems.9–16 Although
most studies of MS have focused on outcomes for adult
animals, pathophysiological alterations in colonic function and
hypothalamic–pituitary–adrenal axis hyperactivity are observable
from a young age.17 We have also demonstrated early changes in
emotional function, with MS infants exhibiting precocious
emergence of adult-like fear relapse and extended fear
retention.18,19 It has been suggested that such emotional and
gastrointestinal changes may be linked, establishing a case for the
investigation of enteric treatments for emotional disorders.20,21
Indeed, there is promising preliminary evidence to support the
use of gastroenteric interventions to reduce the impact of ELS. For
example, probiotics (microorganisms that deliver health benefits
to the host via transient colonization of the gastrointestinal
tract)22 have been shown to reduce depression-like behaviors in
adult MS animals.23 In addition, administration of a probiotic
formulation, Lacidofil, during MS normalizes gut function and
corticosterone release in stressed pups.17 At this stage, it is unclear
what effect probiotic treatment has on the stress hormone levels
and gastrointestinal health of unstressed animals. However, it is
evident that probiotics restore at least some aspects of normal
development and adult behavior following ELS, suggesting that
probiotic treatments hold potential clinical value for stress-
exposed individuals. Therefore, the aim of the current series of
experiments was to establish whether probiotic treatment might
also prevent the alterations in emotional development observed
following ELS. Specifically, this exciting possibility was explored by
examining whether Lacidofil could rescue normal developmental
trajectories of fear retention and extinction in infant rats exposed
to MS stress.
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Experimentally naive Sprague–Dawley-derived rats were bred and housed
in the School of Psychology at The University of New South Wales. Rats
were housed with their dam and littermates (culled to eight pups per litter)
and maintained on a 12-h light/dark cycle (lights on at 0700 hours) with
food and water available ad libitum. The day of birth was designated
postnatal day (P)0. Only male pups were used, with the exception of
Experiments 3b and 4 where dams were tested. Animals were randomly
allocated to groups with no more than one rat from each litter per
experimental group. Group sizes for behavioral experiments were
determined based on previous experiments conducted with infants and
adults in our laboratory, as well as animal availability (see figure captions
for exact group sizes). All data collected for this series of experiments have
been reported in the present paper. All animals were treated in accordance
with The Australian Code of Practice for the Care and Use of Animals for
Scientific Purposes 7th Edition (2004), and the Animal Care and Ethics
Committee at The University of New South Wales approved all procedures.
Apparatus
In Experiment 1, a set of two identical rectangular chambers (13.5 cm
long×9 cm wide× 9 cm high) was used. The front and rear walls and
ceiling were clear Plexiglas, whereas the floor and side walls consisted of
stainless steel rods spaced 1 cm apart. The floor was connected to a
custom-built constant-current shock generator, and two high-frequency
speakers were fitted on either side of the chamber. In Experiment 2, a
second set of rectangular chambers (Context B) was also used that was
distinct from the chambers described above (Context A) in both size and
visual characteristics. The chambers in Context B were larger (30 cm
long×30 cm wide× 23 cm high), and all four walls and the ceiling were
clear Plexiglas, with only the floor being constructed of stainless steel rods.
Two side walls were covered with vertical black and white stripes (5 cm
wide), and two high-frequency speakers were mounted on the ceiling. All
experimental chambers were individually housed in sound-attenuating
wood cabinets fitted with a white light-emitting diode (LED), an infrared
LED and an infrared camera. The infrared LED provided the sole source of
illumination in Context A, whereas both white and infrared LEDs were used
in Context B. Ventilation fans in each cabinet produced a constant low-
level (50 dB) background noise. Chambers were wiped clean with tap
water following each experimental session.
The wood elevated-plus maze (EPM) used in Experiment 3 consisted of
two open arms (10 cm wide× 50 cm long with a 1-cm raised edge) and
two enclosed arms (10 cm wide× 50 cm long with 39-cm high walls)
extending from a central platform (10 cm×10 cm). The entire apparatus
was raised 51 cm above the floor and a video camera was mounted above
the maze. The EPM was wiped clean before and after experimental
sessions with tap water (during testing of infants) or ethanol (during
testing of dams).
Maternal separation
On P2–14, all pups from a given litter were placed together in an incubator,
separate from the dam, for 3 h per day, commencing between 0800 and
1200 hours. The ambient temperature was maintained at ~ 27 °C with a
heat pad. Three centimeters of bedding were provided so that pups could
behaviorally thermoregulate as needed.
Probiotic treatment
A commercially available probiotic formulation, Lacidofil, was provided by
Lallemand Health Solutions (Montreal, QC, Canada). Lacidofil comprises
live Lactobacillus rhamnosus strain R0011 and L. helveticus strain R0052 in
the ratio 95:5. This particular formulation has been used in a number of
published studies (for review, see Foster et al.)24 and was chosen based on
previous findings that it normalizes corticosterone levels in MS infants.17
Powdered Lacidofil was rehydrated in distilled water at a concentration of
109 colony-forming units per milliliter, a dosage based on previous studies
using the same probiotic preparation,25 and provided in dams’ drinking
water from P2 to P14. Distilled water was provided in the vehicle condition.
All drinking solutions were changed every second day to ensure bacteria
viability.
SYBR Green-based quantitative polymerase chain reaction (qPCR) was
used to confirm the presence of L. rhamnosus R0011 in pups’ stomach milk
(Experiment 5). Stomach-milk extraction was performed based on the
procedure described by Fellows and Rasmussen.26 DNA was extracted
using a milk bacterial DNA isolation kit (Norgen Biotek, Thorold, ON,
Canada). qPCR was conducted using primers described by Gareau et al.17
and obtained from Thermo Fisher Scientific (Waltham, MA, USA). A melt
curve analysis verified the reaction specificity. See Supplementary Methods
for further details.
Behavioral procedures
During conditioning in Experiments 1 and 2, rats were placed in Context A
where, after a 2-min adaptation period, six pairings of a white noise
conditioned stimulus (CS; 8 dB above background, 10 s duration) and a
shock unconditioned stimulus (US; 0.6 mA, 1 s) were presented. The US
was administered in the final second of the CS, and the intertrial interval
ranged from 85 s to 135 s, with a mean of 110 s. Rats were returned to their
home cages 30–60 s after the final CS–US pairing.
In Experiment 2, rats were given extinction training the day after
conditioning. Extinction was conducted in Context B and consisted of a 2-
min adaptation (baseline) period followed by 30 non-reinforced presenta-
tions of the 10-s CS with a 10-s intertrial interval. Rats were returned to
their home cages 30–60 s after the final CS presentation. Freezing was
scored using a time-sampling procedure, whereby each rat was scored as
freezing or not freezing every 3 s during the baseline period and each
presentation of the CS. For analysis, data from the 30 extinction trials were
collapsed into five blocks of six trials each.
During test for Experiments 1 and 2, levels of freezing were recorded
throughout a 1-min adaptation period (baseline) and a 2-min presentation
of the CS.
In Experiment 3, the EPM was used as a measure of anxiety. On P17,
either the infants or dams were placed in the center of the EPM facing a
closed arm. Animals were considered to have entered an arm when the
two front paws and the head were on the arm. The latency to enter an
open arm, number of entries into open and closed arms, and time spent in
open and closed arms were recorded for 5 min, after which animals were
returned to the home cage.
For Experiment 4, maternal behavior was assessed using a pup-retrieval
test conducted on P6, when pups are still relatively immobile. Dams were
removed from the home cage for 7 min, during which time pups were
removed from the nest and placed on the opposite side of the home cage
(24.5 cm wide× 37 cm long). On reunion, dams were placed back in the
home cage on the opposite side to pups. The time taken to retrieve pups
to the nest was observed and recorded from an adjacent room via a video
camera positioned above the cage. Dams that did not retrieve all pups to
the nest within a 10-min period were scored at the maximum value (600 s);
the same statistical results were obtained if these litters were excluded
from the final analysis.
Exclusions and statistics
As high levels of baseline freezing make it difficult to detect CS-elicited
freezing, any rat that exhibited460% baseline freezing was excluded from
the final analysis. This resulted in two exclusions (one rat from Group
Vehicle—7 days in Experiment 1 and one rat from Group Probiotic—
Different in Experiment 2). In addition, one rat was excluded from Group
Probiotic—Different in Experiment 2 as it was a statistical outlier (3.7 s.d.
from the mean). Due to significant differences in baseline freezing
between groups (Supplementary Table S1), data are presented and
analyzed as difference scores (percent freezing during the CS minus
percent freezing during baseline). The same pattern of results was
obtained if the data were analyzed by analysis of variance (ANOVA) with
the raw data (ignoring baseline scores) or by analysis of covariance with
baseline freezing as a covariate. Using Levene’s test of equality of
variances, variance was found to be similar for all reported comparisons
(see also s.e.m. values in relevant figures). Two-tailed tests were used
throughout, with values of Po0.05 considered statistically significant.
Where the assumption of sphericity was violated, the Greenhouse Geisser
procedure was used but nominal df are reported. Where the assumption of
normality was violated, non-parametric tests were conducted; in all cases
the same statistical results were obtained, so the ANOVA statistics are
presented for consistency. A random sample (30%) of the test data was
cross-scored by a second observer unaware of subjects’ experimental
condition, with high inter-rater reliability across all experiments
(rs = 0.97–1.00).
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RESULTS
Dam fluid intake
Fluid consumption was monitored daily throughout treatment
(Supplementary Figure S2). Intake increased with pups’ age for
both treatment types. Probiotic-treated dams consumed more
than vehicle-treated dams, although only in the first few days of
treatment (see Supplementary Results for statistical analysis).
Animal weights
Dams and pups were weighed daily throughout MS (Supple-
mentary Figure S3). Pups gained weight across development,
whereas dams lost weight (see Supplementary Results for
analysis). There were no significant differences in weight between
treatment groups, indicating that caloric intake was similar despite
the initial difference in fluid intake. In other words, any potential
change in nutritional intake in the probiotic-exposed animals
was not reflected in a macro measure of energy intake (that is,
weight gain).
Experiment 1: Effect of probiotics on infantile amnesia in MS
infants
Previous work from our laboratory has shown that ELS results in a
precocious transition to an adult-like memory system.19,27 Infantile
amnesia is a well-established phenomenon, whereby standard-
reared (SR) infants exhibit rapid forgetting of learned fear.28,29
However, MS infants retain and express fearful associations for
extended periods of time.19 In Experiment 1, we tested the
hypothesis that a probiotic treatment shown to reduce the
hormonal and gastrointestinal impact of MS17 would also reverse
the impact of MS on infant fear retention.
A 2 × 2 between-subjects design was employed, with the factors
referring to treatment (probiotic or vehicle) and test interval (1 or
7 days). MS infants were conditioned on P17 and tested either 1 or
7 days later.
Test results are presented in Figure 1. The effect of treatment
was nonsignificant (F1,46 = 2.23, P= 0.142), but there was a
significant effect of test interval (F1,46 = 5.18, P= 0.028) and a
significant Treatment × Test Interval interaction (F1,46 = 4.55,
P= 0.038). Follow-up comparisons revealed that probiotic-
exposed rats exhibited significantly less freezing (that is, forget-
ting) at the 7-day test compared with the 1-day test (t21 = 3.46
(95% confidence of interval (CI), 12.64–50.69), P= 0.002). However,
the effect of test interval was nonsignificant for vehicle-exposed
MS rats (t25 = 0.10 (95% CI, − 20.97 to 23.04), P= 0.924).
The results of Experiment 1 replicate our previous finding that
MS infants retain fear memories across extended intervals.19 More
importantly, treating dams with probiotics restored age-
appropriate infantile amnesia in MS pups. This result cannot be
attributed to a reduction in initial learning as both groups
demonstrated equivalent levels of freezing to the CS after 1 day.
Rather, probiotic treatment returned the stressed infants to the
expected phenotype of forgetting observed in unstressed
infant rats.
Experiment 2: Effect of probiotics on fear relapse in MS infants
In Experiment 1 we demonstrated that probiotic treatment
prevents the precocious transition to adult-like fear retention in
stressed infants. ELS also accelerates the transition from a relapse-
resistant extinction phenotype to an adult-like phenotype of fear
relapse. That is, a number of reports demonstrate that SR infant
rodents do not exhibit renewal, reinstatement or spontaneous
recovery of extinguished fear.30 However, infants exposed to ELS
exhibit relapse (at least renewal and reinstatement) following
extinction.18,27 Experiment 2 was designed to test whether
probiotic treatment would prevent the precocious emergence of
relapse-prone extinction in MS infant rats (just as it prevented the
precocious transition to adult-like fear retention in Experiment 1).
The design was a 2 × 2 factorial, with the factors referring to
treatment and test context. P17 rats were conditioned on Day 1,
extinguished on Day 2 and tested on Day 3 in either the same
context as extinction or a different context.
Extinction. The effects of subsequent test context and related
interactions were nonsignificant (largest F1,47 = 1.60, P= 0.212);
therefore, extinction data were collapsed across test context. As
expected, freezing decreased across extinction blocks
(F4,188 = 29.11, Po0.001; Figure 2a). The effect of treatment and
related interactions were nonsignificant (Fso1). In other words,
treatment did not affect levels of conditioned fear or the rate of
extinction.
Test. Whereas the effect of treatment was nonsignificant (Fo1),
there was a significant effect of test context (F1,47 = 9.30, P= 0.004)
and a significant Treatment × Context interaction (F1,47 = 4.82,
P= 0.033; Figure 2b). Follow-up comparisons revealed that
vehicle-exposed MS rats exhibited significantly higher levels of
freezing in the different context than in the same context (that is,
renewal; t20 = 4.03 (95% CI, 18.35–57.70), P= 0.001). However, the
effect of context was nonsignificant for probiotic-exposed MS rats
(t27 = 0.60 (95% CI, − 27.50 to 15.12), P= 0.556).
In Experiment 2, vehicle-exposed MS infants demonstrated
context-mediated renewal of extinguished fear, replicating pre-
vious findings.18 In contrast, probiotic-exposed MS infants did not
show this renewal effect. That is, probiotics restored the age-
appropriate expression of relapse-resistant extinction. This result is
consistent with the findings of Experiment 1, indicating that
treating dams with probiotics attenuates MS-induced acceleration
of both extinction and fear memory development in pups.
Together, these results suggest that a non-invasive probiotic
treatment can reduce expression of persistent, relapse-prone fear
memories in animals exposed to ELS.
Experiment 3a: Effect of MS and probiotics on infants’ anxiety
In Experiments 1 and 2 we observed that probiotics reversed the
effects of MS on two forms of learned fear. Given reports that MS
increases anxiety in adult animals,13,14 it is important to examine
whether the anxious phenotype emerges early in life as well.
Further, some studies have found anxiolytic effects of probiotics in
adult rodents,31,32 suggesting that the present treatment might
also influence anxiety levels in pups. It is possible that anxiety at
the time of training may have influenced the strength of encoding
of the fear memory and thereby influenced test performance.
Thus, in Experiment 3a, the EPM was used to measure infants’
anxiety at the age animals were trained in the first two
experiments (that is, P17). Three groups of animals were tested
Figure 1. Mean (± s.e.m.) CS-elicited freezing at the retention test for
vehicle- and probiotic-exposed maternally separated (MS) infant
rats. Vehicle-exposed MS rats exhibited excellent retention at both
1 day (n= 14) and 7 days (n= 13). Probiotic-exposed MS rats
exhibited good retention at the 1-day interval (n= 13), but age-
appropriate forgetting (that is, infantile amnesia) after 7 days
(n= 10). *Po0.05. CS, conditioned stimulus.
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on the EPM, a widely used and well-validated measure of anxiety
in rodents.33 Two groups were exposed to MS with either
probiotic or vehicle treatment. A group of SR animals was also
tested, as we have not previously compared anxiety in SR and MS
infants.
One-way ANOVAs revealed that the effect of rearing condition
was nonsignificant for all behavioral measures (largest F2,31 = 1.54,
P= 0.229; Figure 3a, b and Supplementary Figure 4a, b). In other
words, neither MS nor probiotics altered pups’ anxiety-like
behavior or locomotor activity (as measured by total number of
arm entries34 on the EPM. This would appear inconsistent with
previous findings that MS increases anxiety13,14 (but see also
Millstein and Holmes35 and Eklund and Arborelius36) and probiotic
treatment decreases anxiety.31,32 However, it is of note that these
studies were all conducted in adulthood, whereas in the present
study we tested infants. Our finding that MS did not increase
anxiety (at least as measured by the EPM) is consistent with the
finding that baseline levels of freezing (which can reflect
generalized anxiety) are not altered in developing MS
animals.18,19,37 The lack of a probiotic effect in these animals is
therefore less surprising in light of previous work showing that
some probiotic strains specifically alter mood or behavior only in
individuals that are symptomatic.23,38,39 Overall, the current data
suggest that MS-induced differences in retention and extinction of
learned fear precede any changes in diffuse levels of anxiety.
Experiment 3b: Effect of MS and probiotics on dams’ anxiety
Although MS and probiotic treatment did not affect pups’ anxiety
in Experiment 3a, it is possible that the effects observed in
Experiments 1 and 2 might be mediated by changes in maternal
behavior. This hypothesis is supported by research showing that
Figure 2. Mean (± s.e.m.) CS-elicited freezing during (a) extinction and (b) test for vehicle- and probiotic-exposed maternally separated (MS)
infant rats. Only vehicle-exposed MS rats demonstrated the renewal effect, that is, higher freezing in the different context (n= 11) compared






































































































Figure 3. Anxiety-like behavior (mean± s.e.m.) on the elevated-plus maze in (a, b) infants and (c, d) dams exposed to standard-rearing
conditions (SR, pups: n= 10, dams: n= 9), maternal separation (MS) with vehicle treatment (MS-Veh, pups: n= 12, dams: n= 8), or MS with
probiotic treatment (MS-Pro, pups: n= 12, dams: n= 8). There were no significant effects of condition on percent entries into open arms or
percent time in open arms.
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providing dams with a foster litter during MS reduces the effects
of separation on offspring hypothalamic–pituitary–adrenal axis
development.40 Further, it has been shown that MS dams exhibit
increased levels of anxiety and depression-like behavior following
weaning of pups.41,42 However, to our knowledge, there have
been no studies examining changes in maternal anxiety as a result
of MS or probiotics while the pups are still under the dam’s care.
Thus, Experiment 3b was designed to test whether MS or probiotic
treatment alters anxiety levels in active mothers. Similar to
Experiment 3a, there were three groups that differed in terms of
the rearing conditions they experienced (SR, MS+vehicle and MS
+probiotics). SR animals were included as we have not previously
compared MS and SR dams on tests of anxiety. Following 2 days of
handling, dams were tested on the EPM when pups reached P17.
One-way ANOVAs revealed that the effect of rearing condition
was nonsignificant for all measures (Fso1; Figure 3c, d,
Supplementary Figure 4c, d). That is, MS, with or without probiotic
treatment, did not alter dams’ anxiety-like behavior or locomotor
activity on the EPM when their pups were 17 days of age (the age
at which the pups were trained in Experiments 1 and 2). Whereas
there are previous reports of increased anxiety-like behavior in MS
dams,42,43 the timing of testing differed vastly between these
studies and the current experiment, with all previous work
focusing on the period after offspring had been weaned. This
would suggest that the effects of MS on maternal anxiety become
apparent only after a delay, indicating that developmental
alterations in infant fear retention and inhibition are not mediated
by changes in maternal anxiety at the time of infants’ training.
Experiment 4: Effect of probiotics on dams’ maternal behavior
In Experiment 3, we found that alterations in infant fear learning
were not mediated by changes in either pup or dam anxiety. An
alternate possible explanation for the observed probiotic effect on
infant behavior in Experiments 1 and 2 is that there may be
changes in mother–infant interactions. For example, there is
abundant evidence that naturally occurring variations in maternal
behavior can alter long-term neuroendocrine and behavioral
outcomes for pups.44 Thus, in Experiment 4 we examined pup-
retrieval, a species-typical maternal response that is regulated by
the hormone oxytocin.45
As shown in Figure 4, probiotic treatment did not alter maternal
responsiveness on the pup-retrieval test. This was the case at both
test time points (that is, at reunion after 3 h of MS and at a delay,
following a 3-h period of being united), with no significant effects
or interactions of treatment or test time on the latency to retrieve
the first or last pup (largest F1,14 = 1.18, P= 0.296). In other words,
the effects of probiotic observed in Experiments 1 and 2 cannot be
explained by alterations in maternal care, at least as assessed by
pup-retrieval.
Experiment 5: Detection of probiotics in pups’ stomachs
To assess for the transmission of the probiotic bacteria to pups,
stomach contents were extracted on P7 and analyzed using qPCR
for the presence of the predominant strain in the probiotic
treatment (L. rhamnosus R0011). This analysis indicated that
L. rhamnosus R0011 was present at detectable levels in the
positive control as well as in stomach milk samples obtained from
probiotic-exposed MS pups (Figure 5). However, no amplification
was observed in stomach milk samples obtained from vehicle-
exposed MS pups. Thus, it is clear that treatment of nursing dams
resulted in transfer of the probiotic to pups, and this was specific
to probiotic-exposed animals.
DISCUSSION
In the present series of experiments we investigated the effects of
a probiotic formulation, Lacidofil, on infant and maternal behavior
in the MS model of ELS. Replicating previous results from our































Figure 4. Mean (± s.e.m.) time for vehicle-treated (n= 9) and probiotic-treated (n= 7) maternally separated dams to retrieve the (a) first pup
and (b) last pup to the nest. There were no significant effects of treatment on retrieval time, regardless of whether the test was conducted
immediately after maternal separation, or at a delay (after a 3-h period of being united).
Figure 5. Mean (± s.d.) threshold cycle (Ct values) for amplification
of L. rhamnosus strain R0011 from stomach milk samples of vehicle-
exposed (n= 3) and probiotic-exposed (n= 3) maternally separated
pups at P7, and a positive control prepared from a vehicle-exposed
sample spiked with probiotic solution. Ct values for all samples in
the vehicle-exposed group were undetermined (includes Ct values
433 or undetermined by the software).
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extended fear retention and relapse-prone extinction. However,
the MS offspring of probiotic-treated dams exhibited age-
appropriate infantile amnesia and relapse-resistant extinction
(Experiments 1 and 2, respectively). The reversal of stress-
induced accelerated maturation in MS infants was not mediated
by changes in pups’ or dams’ levels of anxiety on the EPM
(Experiment 3), nor by changes in maternal responsiveness on the
pup-retrieval test (Experiment 4). The results of Experiment 5
demonstrated that the probiotic was present in the stomach milk
of only the infants from the treated mothers.
Within the growing body of evidence for the importance of
brain–gut–microbiota interactions,46–50 the present study has
exciting clinical implications for the treatment of individuals
exposed to ELS. There is mounting evidence that probiotic
treatments can normalize stress-induced changes throughout the
brain–gut–microbiota axis. For example, probiotics reduce depres-
sive behaviors in adult MS rats and normalize gastrointestinal and
hormonal effects of both ELS and adult stress.17,23,51,52 However,
to our knowledge this is the first demonstration that probiotics
can affect the behavior of young animals exposed to stress.
Specifically, our results show that treating nursing dams with
Lacidofil prevents accelerated emotional development in MS
infants. Whereas maturation and enhanced learning are ordinarily
considered advantageous, it is likely that the specific timing of
development is functionally important. For example, studies of
perceptual systems demonstrate that accelerated development of
one sensory system interferes with normal development of other
species-typical behaviors.53,54 Thus, by restoring the normal
trajectory of fear retention and extinction to levels expected of
standard-reared animals, probiotics may act protectively to
prevent disruptions to as-yet unidentified systems. Furthermore,
preventing inappropriate expression of fear during infancy may
have flow-on effects for inappropriate fear expression, or anxiety,
in adulthood. Indeed, the importance of early childhood fearful
experiences and responding styles is emphasized in many theories
of the etiology of psychopathology.55,56
It will be necessary to test the translational value of the present
findings through clinical trials. Currently, research examining the
effects of probiotics on emotion regulation in humans is sparse
but promising. Two studies in healthy populations have demon-
strated enhanced mood and lower anxiety as a result of probiotic
treatment,32,39 with an additional study demonstrating that
probiotics reduced anxiety in a sample of chronic fatigue
patients.57 Probiotics have also been shown to reduce urinary
levels of the stress hormone cortisol32 and to alter functional
activity of emotion-related brain regions in a sample of healthy
females.58 Most of these studies examined nonclinical populations
and all examined adults, but our results suggest the need to test
probiotic effects in those exposed to ELS. For potential future
trials, the non-invasive nature of the present treatment is perhaps
its most valuable property as it is likely to encourage greater
participation and treatment adherence. Furthermore, the specific
probiotic formulation we used, Lacidofil, is generally well-
tolerated, with no toxicity reported in animal studies and no
serious adverse events reported in commercial applications.24
Lacidofil has also been used in multiple studies of pediatric
populations with various forms of gastrointestinal dysfunction,24
paving the way for future clinical trials with individuals exposed to
ELS. Clinical testing in this area is imperative, given the highly
specific nature of probiotics; different strains are known to have
different effects and mechanisms of action22,59 and the action of
individual strains may vary depending on context. For example,
another probiotic formulation was found to be beneficial for
stressed animals but resulted in MS-like changes when adminis-
tered in the absence of stress.60 A limitation of the present study is
that the effects of Lacidofil on standard-reared animals was not
investigated, which will be an important area for future studies.
Although the emerging evidence, including the present study,
suggests that probiotics may be useful in treating stressed
individuals, the mechanisms remain unclear. There are a number
of potential pathways for the observed effects. In the present case,
treatment was administered to pups indirectly via the dam,
suggesting that the mother may mediate the changes in pups’
behavior, a hypothesis supported by previous work on the
importance of the maternal experience of MS for infant
outcomes.40 However, we did not observe differences in dams’
levels of anxiety or maternal responsiveness during pups’ early life.
Although this does not exclude the possibility that some other
aspect of maternal behavior might be altered, the fact that the
probiotic was passed on to pups via dams’ breast milk supports a
more direct mode of action.
Given the complex nature of the brain–gut–microbiota interac-
tion, it is likely that probiotic colonization would result in multiple
changes that may have contributed to the observed effects on
pups’ emotional development. First, modulation of immune
function is an important intermediary in the communication
between the brain and the gut. The sheer size of the gut–
environment interface (the body’s largest immune interface)
necessitates a complex, regionally diverse immune system that
is dependent on the commensal bacteria to develop and maintain
immune homeostasis.61,62 The specific probiotic formulation used
here has been shown to modulate immune function via down-
regulation of pro-inflammatory cytokines and restoration of gut
barrier function.24 This is particularly relevant as MS animals
exhibit a pro-inflammatory profile in keeping with the inflamma-
tory hypothesis of depression.63,64 A second possibility is that
probiotics serve to produce (or stimulate production of) neuroac-
tive compounds that may influence neural signaling via the
enteric nervous system or vagal afferents.65,66 As one example, the
serotonergic system has a key role in emotion regulation and is
known to be disrupted by ELS.67,68 Interestingly, commensal
bacteria and probiotic species have been shown to influence
tryptophan metabolism, leading to altered serotonin levels in the
plasma, as well as in cortical and subcortical regions of the
brain.66,69,70 Finally, hypothalamic–pituitary–adrenal axis regula-
tion is another important candidate mechanism for the observed
effects, particularly in light of our prior research implicating
corticosterone in the accelerated development of MS animals19,71
and evidence that Lacidofil normalizes corticosterone levels in MS
pups.17 Although it will be important for future research to
determine the exact mechanism(s) involved, it is clear that,
regardless of the pathway, the probiotic formulation acted as a
potent treatment to reverse the effects of ELS on infants’ learned
emotion-related behaviors in an effective and non-invasive
manner.
In conclusion, our data show that probiotic treatment reverses
the effects of MS on learned fear responses during infancy,
rescuing the normal developmental trajectory in stressed infants.
Alongside evidence that probiotics reduce the hormonal response
to MS,17 these results indicate that further investigation is
warranted to explore the clinical implications of these findings
for the treatment of individuals exposed to ELS. In addition,
elucidation of the mechanisms for the observed behavioral
changes will be a critical line of investigation for future research.
Overall, the results presented here highlight the utility of animal
models in examining the developmental effects of probiotics and
add to the growing body of research highlighting the importance
of the brain–gut–microbiota axis for mental health and emotional
development.
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